Disclosures / Herzberg, Dr. Max
T9G
Vidac Pharma Holding PLC
Amount
€10K
@ €0.57 / per share
Detailed Analysis
Dr. Max Herzberg, a Management Board member at Vidac Pharma Holding PLC, sold €5,700 worth of shares at €0.57 on April 30, 2026. This open-market sale carries limited analytical weight as routine share dispositions lack the predictive signal of concentrated insider accumulation or forced selling. The modest transaction size and seven-day disclosure lag suggest standard portfolio management rather than time-sensitive signaling.
Price history — T9G
Price since trade
—
SPY since trade
—
No price data available
Trade date
30 April 2026
When the trade occurred
Disclosed date
07 May 2026
7-day delay
Disclosure delay: 7 days. This trade was reported to regulators 7 days after it occurred. By the time this filing became public, markets had 7 additional days to react to any non-public information.
Reference data
Use these identifiers to look up this instrument in your own platform. Disclosyr does not link to any broker.
Ticker
T9G
ISIN
GB00BM9XQ619
Exchange
XETR
Company
Vidac Pharma Holding PLC
Filed with bafin germany on 07 May 2026